With only three cases sequenced globally, it hasn't been given an official name - although some are referring to it as BA.6 or the 'Pi' variant.
It has only been sequenced three times, twice in Denmark and once in Israel, having first been identified in Denmark on 24 July.
Professor Andrew Easton, a virologist at the University of Warwick, explains:"Some mutations are damaging to the virus, some are neutral so don't have any impact at all, and others may benefit the virus. Professor Christina Pagel, an expert in operational research at UCL, adds that although it is"very, very early days" it has"a lot of new mutations that make it very different to previous Omicron strains".
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Key biological pathway reveals insights into long COVID brain fogResearchers from University of New South Wales Sydney and St. Vincent's Hospital have identified a key pathway, involved in inflammation, which appears to be activated in people with long COVID who have symptoms of 'brain fog.'
Lire la suite »
This Sensation In Your Legs Could Actually Be A Long Covid SymptomKeep an eye out for it.
Lire la suite »
Scientists issue warning over Covid rise suggesting masks should be worn againA new sub-strain, which has not yet been formally named, has been identified
Lire la suite »
Study uses genomic data to produce high-resolution serial interval estimates for COVID-19Researchers developed an approach for integrating whole-genomic viral sequences and epidemiological information for serial interval (SI) estimation.
Lire la suite »
Quantitative biological strategy helps upgrade vaccines against COVID-19Researchers from the Shenzhen Institute of Advanced Technology (SIAT) of the Chinese Academy of Sciences (CAS) and the University of Hong Kong, along with their collaborators, have proposed a promising quantitative biological strategy for dynamic updates of vaccines against SARS-CoV-2 virus. They demonstrated that a vaccine based on the ancestral SARS-CoV-1 strain could offer more extended and broader protection than other options.
Lire la suite »